Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Metal Sky Star Acquisition CorpMetal Sky Star Acquisition Corporation Reports Significant Net Loss and Operational Challenges in Q3 2025
CIM GROUP, INC.CIM Real Estate Finance Trust Reports Q3 2025 Financial Results with $30.3M Net Income
StubHub Holdings, Inc.StubHub Reports 7.9% Revenue Growth but $1.295 Billion Net Loss in Q3 2025
CENTURY CASINOS INC /CO/Century Casinos Reports Q3 2025 Revenue Decline and Increased Net Loss
OLENOX INDUSTRIES INC.Safe & Green Holdings Reports 41% Revenue Decline and Significant Operating Losses in Latest 10-Q
Columbus Circle Capital Corp. IColumbus Circle Capital Corp I Reports $1.6M Net Income in Q3 2025, IPO Raises $250M
Nauticus Robotics, Inc.Nauticus Robotics Reports 434% Revenue Growth to $1.98 Million in Q3 2025
Z Squared Inc.Coeptis Therapeutics Reports Revenue Growth and Increased Losses in Q3 2025
Verses AI Inc.Verses AI Inc. Reports Revenue Decline and Increased Net Loss for Quarter Ended September 30, 2025
P3 Health Partners Inc.P3 Health Partners Reports Q3 2025 Revenue Decline and Net Loss
Clipper Realty Inc.Clipper Realty Inc. Reports Q3 2025 Financial Results with Increased Revenues and Higher Net Loss
SAB Biotherapeutics, Inc.SAB Biotherapeutics Reports $45.4 Million Net Income in Q3 2025, Driven by Warrant Liabilities Gain
Inhibrx Biosciences, Inc.Inhibrx Biosciences Reports $1.3M Revenue in Q3 2025, Net Loss Decreases to $35.3M
SpringBig Holdings, Inc.SpringBig Holdings Reports 4% Revenue Decline in Q3 2025, Achieves Operational Profit
Real Asset Acquisition Corp.Real Asset Acquisition Corp. Reports Significant Asset Growth and Net Income in Q3 2025
NEXPOINT DIVERSIFIED REAL ESTATE TRUSTNexPoint Diversified Real Estate Trust Reports 21.4% Revenue Decline in Latest Quarter
Onconetix, Inc.Onconetix Reports 25.4% Revenue Decline in Q3 2025, Shifts Focus to Proclarix
Marker Therapeutics, Inc.Marker Therapeutics Reports 36% Revenue Decline in Q3 2025, Net Loss of $2.0 Million
QUEST PATENT RESEARCH CORPQuest Patent Research Reports No Revenue and Increased Losses in Latest 10-Q Filing
Nixxy, Inc.Nixxy, Inc. Reports 23,387% Revenue Growth in Q3 2025, Reduces Net Loss
Nuvve Holding Corp.Nuvve Holding Corp. Reports 17% Revenue Decline and Increased Operating Loss in Q3 2025
SPECIFICITY, INC.Specificity, Inc. Reports 21.8% Revenue Growth in Q3 2025, Net Loss Improves
Mitesco, Inc.Mitesco Reports Significant Q3 Revenue Decline and Net Loss Amid Strategic Shift
Quantum Genesis AI Corp.Quantumzyme Corp. Reports No Revenue and Increased Net Loss for Fiscal Year Ending July 31, 2025
CISO Global, Inc.CISO Global Reports $6.46 Million Revenue in Q3 2025, Net Income Improves